Amphiphilic entity nanoparticles
AssigneeAnterios, Inc.
InventorTimothy Kotyla
Life of this patent
Estimating the term…
Abstract
The present invention provides nanoparticle compositions comprising AE nanoparticles. The present invention provides AE nanoparticles comprising one or more amphiphilic entities and pharmaceutical compositions comprising AE nanoparticles. The present invention provides methods of manufacturing AE nanoparticles. The present invention provides methods of delivering a biologically active agent to a subject by administering AE nanoparticles containing a biologically active agent to a subject.
Claims21
1-186. (canceled)
A method for treating a subject having a dermatological condition, the method comprising transdermally administering to the subject a nanoemulsion comprising a population of particles in a dispersion medium and a botulinum toxin,
- wherein the nanoemulsion comprises oily particles dispersed within an aqueous dispersion medium, or wherein the nanoemulsion comprises aqueous particles dispersed within an oily dispersion medium;
- wherein the majority of particles have diameters between 10 and 300 nanometers;
- wherein the particles comprise one or more amphiphilic entities;
- wherein said one or more amphiphilic entities is hyaluronic acid,
- wherein the nanoemulsion penetrates the skin of the subject without changing or altering the structure of the skin;
- thereby treating the subject having the dermatological condition.
Dependencies are inferred from the claim text.